Blood components – non-specific physical interaction

Blood components – non-specific physical interaction is a functional classification used in pharmacology to describe therapeutic agents that exert their effects through physical or chemical changes in the blood rather than by binding to a specific molecular target like a receptor or enzyme (ChEMBL, 2024). This category primarily includes osmotic diuretics, such as mannitol, which increase the osmolality of the plasma to draw fluid from the intracellular or interstitial space into the bloodstream, and plasma volume expanders like dextran, which increase oncotic pressure to stabilize circulatory volume (StatPearls, 2023; NCBI, 2021). Because these interactions are non-specific and depend on the bulk properties of the plasma, they are frequently employed in critical care to manage conditions such as cerebral edema, increased intraocular pressure, and hypovolemic shock (PubMed, 2022). However, the lack of molecular specificity means these agents can significantly impact systemic fluid and electrolyte balance, necessitating careful clinical monitoring of renal function and cardiovascular status. This designation serves as a catch-all for drugs whose primary mode of action is mediated by the physical environment of the circulatory system rather than a discrete biological molecule.

Other names

Non-specific plasma interactionPhysical blood interactionOsmotic and oncotic agentsNon-specific interaction with blood components

The mechanism involves the physical alteration of the blood's properties, such as increasing plasma osmolality or oncotic pressure, to induce fluid shifts from tissues into the vasculature or to maintain intravascular volume without binding to a specific molecular receptor.